Glucose metabolism disorder: a potential accomplice of SARS-CoV-2

Yi Luan1, Ying Luan2, Hongbo He3

  • 1Department of Translational Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Insights

This review highlights how diabetes and glucose metabolism disorders worsen SARS-CoV-2 (CoV-2) infection outcomes. Targeting these metabolic issues may offer new treatments for severe CoV-2 disease.

Area of Science:

  • Metabolic Medicine
  • Infectious Diseases
  • Molecular Biology

Background:

  • Over 265 million SARS-CoV-2 (CoV-2) cases and 5.2 million deaths reported globally.
  • Individuals with type 2 diabetes mellitus (T2DM) face increased risk of severe CoV-2 infection.
  • Established link between glucose metabolism and CoV-2 progression.

Purpose of the Study:

  • To review the association between glucose metabolism disorders and CoV-2 progression.
  • To elucidate the impact of diabetes on CoV-2 severity.
  • To identify therapeutic targets within glucose metabolism for CoV-2 treatment.

Main Methods:

  • Literature review synthesizing evidence on glucose metabolism and CoV-2.
  • Analysis of key proteins and pathways regulating glucose metabolism.
  • Exploration of potential interventions targeting metabolic disorders.

Main Results:

  • Glucose metabolism disorders, including T2DM, promote severe CoV-2 progression.
  • Specific proteins and pathways in glucose metabolism significantly influence CoV-2 outcomes.
  • Targeting metabolic dysregulation presents a promising therapeutic strategy.

Conclusions:

  • Dysregulated glucose metabolism exacerbates SARS-CoV-2 (CoV-2) infection.
  • Interventions aimed at glucose metabolism disorders could be crucial for managing CoV-2.
  • This review offers a metabolic perspective for CoV-2 treatment strategies.

Related Concept Videos

Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.2K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
989
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
590
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
297